Losartan in Black / African Ancestry Patients: Dose Adjustments and Clinical Considerations
Evidence-based guide to losartan dosing, pharmacogenomics, and clinical outcomes in Black and African ancestry patients, including LIFE trial subgroup data, CYP2C9 pharmacogenomics, and JNC/ACC/AHA guideline context.